Braun Stacey Associates’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.7M Sell
234,879
-1,163
-0.5% -$120K 0.67% 60
2026
Q1
$22.8M Buy
236,042
+13,549
+6% +$1.39M 0.76% 55
2025
Q4
$23.6M Sell
222,493
-1,180
-0.5% -$137K 0.77% 56
2025
Q3
$28.4M Buy
223,673
+18,967
+9% +$2.26M 0.93% 34
2025
Q2
$25.1M Buy
204,706
+81,501
+66% +$9.31M 0.91% 40
2025
Q1
$12.5M Buy
123,205
+18,298
+17% +$1.79M 0.51% 75
2024
Q4
$9.69M Buy
+104,907
New +$10.3M 0.36% 85

Other funds holding EHC

Braun Stacey Associates's EHC Position: Q2 2026 in Review

Braun Stacey Associates reduced its Encompass Health (EHC) stake by 0.49% in Q2 2026, selling an estimated $120K and leaving 234,879 shares worth $23.7M. The position accounts for 0.67% of the portfolio, ranked #60.

Braun Stacey Associates first reported a position in EHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $28.4M in Q3 2025. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Braun Stacey Associates held 234,879 shares of Encompass Health worth $23.7M as of Q2 2026.
  • Braun Stacey Associates sold 1,163 Encompass Health shares in Q2 2026, an estimated $120K.
  • Encompass Health made up 0.67% of Braun Stacey Associates's portfolio in Q2 2026, its #60 holding.
  • Braun Stacey Associates first reported a position in Encompass Health in Q4 2024 and has held it in 7 quarters since.
  • Braun Stacey Associates's Encompass Health position peaked at $28.4M in Q3 2025.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Braun Stacey Associates's 13F filing for Q2 2026, filed 5 Aug 2026.